guaiacol has been researched along with oxyquinoline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Abid, M; Aneja, B; Daniliuc, CG; Irfan, M; Khan, SI; Manzoor, N; Yadava, U | 1 |
Hong, KB; Kang, S; Kim, D; Kim, H; Lee, J; Lee, M; Park, E; Song, JY; Song, KH; Van Manh, N | 1 |
4 other study(ies) available for guaiacol and oxyquinoline
Article | Year |
---|---|
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds.
Topics: Animals; Antifungal Agents; Candida albicans; Candida tropicalis; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Hemolysis; Humans; Quantitative Structure-Activity Relationship; Triazoles; Vero Cells | 2015 |
2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPĪ± Checkpoint.
Topics: | 2022 |